Figure 2

Framingham risk score-adjusted odds ratio and 95% confidence interval per 10 ml/min/1.73 m² decrease in eGFR in the whole cohort and those free of ASVD at baseline. ASVD atherosclerotic vascular disease, eGFR estimated glomerular filtration rate, MDRD Modification.